Vaginal dinoprostone versus placebo for pain relief during intrauterine device insertion: a systematic review and meta-analysis of randomised controlled trials

Abu‐Zaid, Ahmed; Alshahrani, Majed Saeed; Albezrah, Nisreen Aref; Miski, Najlaa Talat; Abuzaid, Mohammed; Aboudi, Saud; Baredwan, Ahlam; Almadhi, Nada H; Baradwan, Afnan; Alomar, Osama; Salem, Hany; Al‐Badawi, Ismail A.; Baradwan, Saeed

doi:10.1080/13625187.2021.1891411

Cited by 5 publications

(3 citation statements)

References 39 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The majority of our respondents reported offering some type of analgesic for IUD insertion, and NSAIDs were the predominant form of analgesic offered (39.68%). This is consistent with current research that supports the efficacy of NSAID use in IUD insertion [4,5]. Additional analgesics utilized were paracervical block, misoprostol, and lidocaine gel.…”

Section: Surveysupporting

confidence: 88%

“…Pain reduction therapies for IUD insertion have been widely investigated with mixed results. Studies have reported lidocaine paracervical block [3,4], vaginal or orally administered misoprostol or other prostaglandins [5], and non-steroidal anti-inflammatory drugs [6,7] as effective. Other studies investigating the use of the same analgesic drugs found no efficacy [8][9][10][11][12][13][14][15].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Provider Perspectives on Analgesic Use in Intrauterine Device Insertion Procedures: A Mixed Methods Analysis

Daidone,

Morris,

Colquitt

et al. 2024

Cureus

View full text Add to dashboard Cite

Context: The intrauterine device (IUD) is one type of long-acting reversible contraceptive that is becoming increasingly popular among patients and healthcare providers alike, though many are deterred from using this option due to pain or fear of pain with IUD insertion. While the IUD insertion process itself is standardized, the use of pain medication is not. There is a lack of research regarding provider preference in analgesic use for IUD insertion procedures, which analgesics are being provided to patients, and under which circumstances. This study aims to explore which analgesics are being used routinely in clinical settings, which patient populations are more likely to receive or benefit from these treatments, and why. Secondarily, this study aims to evaluate the impacts of provider characteristics such as location of training and practice, length of practice, and type of training in analgesic administration.Methods: Various national organizations were contacted via email and asked to distribute the "IUD Pain Management" survey via discussion board or email newsletter. This survey was developed to gather demographic information on providers of IUD placement procedures and evaluate trends in analgesic methods used based on provider and patient characteristics. Additionally, the survey included an opportunity for participants to agree to participate in a brief interview to further elaborate on their responses via phone. Survey responses were collected and evaluated on the secure QuestionPro platform. Results from the interview were qualitatively assessed by coding recurrent themes between participant interviews.Results: Survey respondents represented physicians from family medicine and OB-GYN specialties, as well as nurse practitioners, registered nurses, physician assistants, and OB-GYN resident physicians. The average length of clinical practice is 6.7 years. The majority of respondents reported offering some sort of analgesic for IUD insertion procedures, with nonsteroidal anti-inflammatory drugs being the most commonly used. Participants also reported an increased likelihood of prescribing analgesics for adolescent and nulliparous patients. Participant interviews included themes such as patient perception of pain, provider training, barriers to access, and alternative analgesic options.Conclusions: Our study has identified a significant amount of variation in practices regarding analgesic use for IUD insertion procedures and highlighted some underlying causes of these inconsistencies. Future studies should further investigate trends in analgesic administration in IUD insertion procedures with a larger sample size and delve into factors such as provider education and barriers to access.

show abstract

Section: Surveysupporting

confidence: 88%

Section: Introductionmentioning

confidence: 99%

Provider Perspectives on Analgesic Use in Intrauterine Device Insertion Procedures: A Mixed Methods Analysis

Daidone,

Morris,

Colquitt

et al. 2024

Cureus

View full text Add to dashboard Cite

show abstract

“…Since the introduction of the intrauterine device (IUD) in the previous century, it has been a popular method of contraception given its high efficiency, convenience, low cost, and long-term effectiveness. It is a long-acting reversible contraceptive (LARC) and one of the most effective and safest contraceptive methods, 1 and almost all women are suitable for IUDs. 2 Copper-containing IUDs can last 10-12 years, while levonorgestrel-releasing IUDs last between 3 and 7 years.…”

Section: Introductionmentioning

confidence: 99%

Uterine Artery Rupture Caused by IUD Extraction: A Case Report

Wang¹,

Sun²

2022

IJWH

View full text Add to dashboard Cite

Analgesic effects of LI4 acupuncture during intrauterine device insertion: a randomized controlled clinical trial

Erdoğan,

Yardımcı

2023

Arch Gynecol Obstet

View full text Add to dashboard Cite

Vaginal dinoprostone versus placebo for pain relief during intrauterine device insertion: a systematic review and meta-analysis of randomised controlled trials

Cited by 5 publications

References 39 publications

Provider Perspectives on Analgesic Use in Intrauterine Device Insertion Procedures: A Mixed Methods Analysis

Provider Perspectives on Analgesic Use in Intrauterine Device Insertion Procedures: A Mixed Methods Analysis

Uterine Artery Rupture Caused by IUD Extraction: A Case Report

Analgesic effects of LI4 acupuncture during intrauterine device insertion: a randomized controlled clinical trial

Contact Info

Product

Resources

About